As Bears Take a Victory Lap, Evaluating this Long Thesis
Research - After a brutal session for the biotech sector (NBI dropped 6% for the day) ESPR fell another $3 in after hours on one particular line in a Monday afternoon press release.
PremiumAuthor Archives: Editorial Staff
Let’s List All of the Events Impacting Sentiment for Equities…
Insights - The NASDAQ Biotech Index (NBI) ended the week on a low note – just 2 percentage points from giving back the entirety of its gains … Continue Reading
Read now
A Mid-September Biotech Update
Research - What a crazy end of summer. Thankfully, today’s the first day of Fall. We’ve got a bunch of updates – insights and administrative – for … Continue Reading
Premium
A Roundup of this Week’s Market/Biotech Events
Insights - The long-awaited September meeting of the FOMC takes place this coming Thursday. Market participants are unusually attuned to this particular meeting due to the ongoing … Continue Reading
Read now
A September Market Update
Research - Last week was yet another exhausting, anemic few sessions in the markets. One day we're up, and the next we're down - with gaps nonetheless - but a trend is non-existent.
PremiumHere’s a Deal for Your Three-Day Weekend…
Insights - After the last two weeks, everyone’s ready for a 3-day break. August closed out with the S&P 500 down 6%, and the NASDAQ Biotech Index … Continue Reading
Read nowMight Ariad Pharma Finally be Bought?
Insights - That was the rumor on anyway, sending shares of Ariad Pharmaceuticals (ARIA) higher by 40% in the Friday trading session. Bloomberg reported at noon on … Continue Reading
Read now